Automatic segmentation and classification of breast lesions through identification of informative multiparametric PET/MRI features.


Journal

European radiology experimental
ISSN: 2509-9280
Titre abrégé: Eur Radiol Exp
Pays: England
ID NLM: 101721752

Informations de publication

Date de publication:
27 04 2019
Historique:
received: 22 10 2018
accepted: 07 03 2019
entrez: 29 4 2019
pubmed: 29 4 2019
medline: 18 9 2020
Statut: epublish

Résumé

Multiparametric positron emission tomography/magnetic resonance imaging (mpPET/MRI) shows clinical potential for detection and classification of breast lesions. Yet, the contribution of features for computer-aided segmentation and diagnosis (CAD) need to be better understood. We proposed a data-driven machine learning approach for a CAD system combining dynamic contrast-enhanced (DCE)-MRI, diffusion-weighted imaging (DWI), and The CAD incorporated a random forest (RF) classifier combined with mpPET/MRI intensity-based features for lesion segmentation and shape features, kinetic and spatio-temporal texture features, for lesion classification. The CAD pipeline detected and segmented suspicious regions and classified lesions as benign or malignant. The inherent feature selection method of RF and alternatively the minimum-redundancy-maximum-relevance feature ranking method were used. In 34 patients, we report a detection rate of 10/12 (83.3%) and 22/22 (100%) for benign and malignant lesions, respectively, a Dice similarity coefficient of 0.665 for segmentation, and a classification performance with an area under the curve at receiver operating characteristics analysis of 0.978, a sensitivity of 0.946, and a specificity of 0.936. Segmentation but not classification performance of DCE-MRI improved with information from DWI and FDG-PET. Feature ranking revealed that kinetic and spatio-temporal texture features had the highest contribution for lesion classification. Our CAD enables the assessment of the relevance of mpPET/MRI features on segmentation and classification accuracy. It may aid as a novel computational tool for exploring different modalities/features and their contributions for the detection and classification of breast lesions.

Sections du résumé

BACKGROUND
Multiparametric positron emission tomography/magnetic resonance imaging (mpPET/MRI) shows clinical potential for detection and classification of breast lesions. Yet, the contribution of features for computer-aided segmentation and diagnosis (CAD) need to be better understood. We proposed a data-driven machine learning approach for a CAD system combining dynamic contrast-enhanced (DCE)-MRI, diffusion-weighted imaging (DWI), and
METHODS
The CAD incorporated a random forest (RF) classifier combined with mpPET/MRI intensity-based features for lesion segmentation and shape features, kinetic and spatio-temporal texture features, for lesion classification. The CAD pipeline detected and segmented suspicious regions and classified lesions as benign or malignant. The inherent feature selection method of RF and alternatively the minimum-redundancy-maximum-relevance feature ranking method were used.
RESULTS
In 34 patients, we report a detection rate of 10/12 (83.3%) and 22/22 (100%) for benign and malignant lesions, respectively, a Dice similarity coefficient of 0.665 for segmentation, and a classification performance with an area under the curve at receiver operating characteristics analysis of 0.978, a sensitivity of 0.946, and a specificity of 0.936. Segmentation but not classification performance of DCE-MRI improved with information from DWI and FDG-PET. Feature ranking revealed that kinetic and spatio-temporal texture features had the highest contribution for lesion classification.
CONCLUSION
Our CAD enables the assessment of the relevance of mpPET/MRI features on segmentation and classification accuracy. It may aid as a novel computational tool for exploring different modalities/features and their contributions for the detection and classification of breast lesions.

Identifiants

pubmed: 31030291
doi: 10.1186/s41747-019-0096-3
pii: 10.1186/s41747-019-0096-3
pmc: PMC6486931
doi:

Substances chimiques

Contrast Media 0
Radiopharmaceuticals 0
Fluorodeoxyglucose F18 0Z5B2CJX4D

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

18

Subventions

Organisme : Austrian Science Fund FWF
ID : I 2714
Pays : Austria
Organisme : NCI NIH HHS
ID : P30 CA008748
Pays : United States

Références

Radiol Clin North Am. 2000 Jul;38(4):725-40
pubmed: 10943274
Br Med J. 1976 Feb 21;1(6007):439-42
pubmed: 1252784
Magn Reson Med. 2003 Jul;50(1):92-8
pubmed: 12815683
Eur Radiol. 2004 Jul;14(7):1217-25
pubmed: 15034745
Invest Radiol. 2005 Jun;40(6):355-62
pubmed: 15905722
IEEE Trans Pattern Anal Mach Intell. 2005 Aug;27(8):1226-38
pubmed: 16119262
IEEE Trans Med Imaging. 2005 Oct;24(10):1256-66
pubmed: 16229413
Acad Radiol. 2006 Jan;13(1):63-72
pubmed: 16399033
Med Phys. 2006 Aug;33(8):2878-87
pubmed: 16964864
J Magn Reson Imaging. 2007 Jan;25(1):89-95
pubmed: 17154399
J Magn Reson Imaging. 2007 Mar;25(3):495-501
pubmed: 17279534
Comput Med Imaging Graph. 2007 Jun-Jul;31(4-5):198-211
pubmed: 17349778
Magn Reson Med. 2007 Sep;58(3):562-71
pubmed: 17763361
Phys Med Biol. 2007 Dec 7;52(23):6991-7006
pubmed: 18029989
IEEE Trans Med Imaging. 2008 May;27(5):688-96
pubmed: 18450541
Acad Radiol. 2008 Dec;15(12):1513-25
pubmed: 19000868
Acad Radiol. 2009 Jul;16(7):842-51
pubmed: 19409817
BMC Bioinformatics. 2009 Jul 10;10:213
pubmed: 19591666
Med Phys. 2009 Jun;36(6):2052-68
pubmed: 19610294
Invest Radiol. 2009 Sep;44(9):553-8
pubmed: 19652611
Med Phys. 2009 Jul;36(7):3192-204
pubmed: 19673218
Med Image Anal. 2010 Apr;14(2):87-110
pubmed: 20071209
J Digit Imaging. 2011 Jun;24(3):446-63
pubmed: 20508965
Acad Radiol. 2010 Jul;17(7):822-9
pubmed: 20540907
Imaging Med. 2010 Jun 1;2(3):313-323
pubmed: 20835372
Neuroimage. 2011 Feb 1;54(3):2033-44
pubmed: 20851191
Int J Cancer. 2010 Dec 15;127(12):2893-917
pubmed: 21351269
Inf Process Med Imaging. 2011;22:245-56
pubmed: 21761661
Eur Radiol. 2012 Feb;22(2):322-30
pubmed: 21913060
J Magn Reson Imaging. 2011 Dec;34(6):1341-51
pubmed: 21965159
Radiology. 2012 Apr;263(1):64-76
pubmed: 22438442
Med Phys. 2013 Mar;40(3):032305
pubmed: 23464337
Invest Radiol. 2014 Jun;49(6):421-30
pubmed: 24566292
Clin Cancer Res. 2014 Jul 1;20(13):3540-9
pubmed: 24963052
Med Image Anal. 2015 Feb;20(1):265-74
pubmed: 25532510
Eur J Nucl Med Mol Imaging. 2015 Oct;42(11):1656-1665
pubmed: 26121928
Med Phys. 1998 Sep;25(9):1647-54
pubmed: 9775369

Auteurs

Wolf-Dieter Vogl (WD)

Computational Imaging Research Laboratory, Department of Biomedical Imaging and Image-guided Therapy, Medical University Vienna, Waehringer Guertel 18-20, 1090, Vienna, Austria.

Katja Pinker (K)

Division of Molecular and Gender Imaging, Department of Biomedical Imaging and Image-guided Therapy, Medical University Vienna, 1090, Vienna, Austria.
Department of Radiology, Breast Imaging Service, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA.

Thomas H Helbich (TH)

Division of Molecular and Gender Imaging, Department of Biomedical Imaging and Image-guided Therapy, Medical University Vienna, 1090, Vienna, Austria.

Hubert Bickel (H)

Division of Molecular and Gender Imaging, Department of Biomedical Imaging and Image-guided Therapy, Medical University Vienna, 1090, Vienna, Austria.

Günther Grabner (G)

MR Center of Excellence, Department of Biomedical Imaging and Image-guided Therapy, Medical University Vienna, 1090, Vienna, Austria.
Department of Radiologic Technology, Carinthia University of Applied Sciences, Klagenfurt, Austria.

Wolfgang Bogner (W)

MR Center of Excellence, Department of Biomedical Imaging and Image-guided Therapy, Medical University Vienna, 1090, Vienna, Austria.

Stephan Gruber (S)

MR Center of Excellence, Department of Biomedical Imaging and Image-guided Therapy, Medical University Vienna, 1090, Vienna, Austria.

Zsuzsanna Bago-Horvath (Z)

Department of Pathology, Medical University Vienna, 1090, Vienna, Austria.

Peter Dubsky (P)

Department of Surgery, Medical University Vienna, 1090, Vienna, Austria.

Georg Langs (G)

Computational Imaging Research Laboratory, Department of Biomedical Imaging and Image-guided Therapy, Medical University Vienna, Waehringer Guertel 18-20, 1090, Vienna, Austria. georg.langs@meduniwien.ac.at.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH